MHIM
ABBV icon

MacNealy Hoover Investment Management’s AbbVie ABBV Stock Holding History

MacNealy Hoover Investment Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$2.55M Sell
33,679
-3,750
-10% -$257K 2.06% 14
2019
Q2 		$2.72M Buy
37,429
+12,050
+47% +$947K 2.06% 14
2019
Q1 		$2.04M Buy
25,379
+175
+0.7% +$14.3K 1.58% 21
2018
Q4 		$2.32M Buy
25,204
+425
+2% +$37.4K 2.02% 13
2018
Q3 		$2.34M Buy
24,779
+475
+2% +$45K 1.72% 20
2018
Q2 		$2.25M Hold
24,304
– – 1.75% 18
2018
Q1 		$2.3M Sell
24,304
-219
-0.9% -$24.1K 1.84% 18
2017
Q4 		$2.37M Sell
24,523
-1,040
-4% -$98K 1.71% 18
2017
Q3 		$2.27M Buy
25,563
+56
+0.2% +$4.26K 1.63% 20
2017
Q2 		$1.85M Hold
25,507
– – 1.41% 25
2017
Q1 		$1.66M Sell
25,507
-512
-2% -$32.2K 1.27% 28
2016
Q4 		$1.63M Sell
26,019
-55
-0.2% -$3.36K 1.25% 27
2016
Q3 		$1.64M Sell
26,074
-1,450
-5% -$93.9K 1.32% 24
2016
Q2 		$1.7M Hold
27,524
– – 1.37% 22
2016
Q1 		$1.57M Sell
27,524
-100
-0.4% -$5.57K 1.28% 26
2015
Q4 		$1.64M Sell
27,624
-200
-0.7% -$11.5K 1.37% 24
2015
Q3 		$1.51M Buy
27,824
+80
+0.3% +$5.21K 1.36% 25
2015
Q2 		$1.86M Sell
27,744
-110
-0.4% -$7.18K 1.53% 21
2015
Q1 		$1.63M Sell
27,854
-500
-2% -$30.2K 1.41% 27
2014
Q4 		$1.85M Sell
28,354
-750
-3% -$47.3K 1.58% 20
2014
Q3 		$1.68M Sell
29,104
-500
-2% -$27.8K 1.48% 23
2014
Q2 		$1.67M Sell
29,604
-600
-2% -$31.5K 1.46% 26
2014
Q1 		$1.55M Sell
30,204
-525
-2% -$26.5K 1.39% 26
2013
Q4 		$1.62M Buy
+30,729
New +$1.51M 1.51% 24

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

MacNealy Hoover Investment Management's ABBV Position: Q3 2019 in Review

MacNealy Hoover Investment Management reduced its AbbVie (ABBV) stake by 10% in Q3 2019, selling an estimated $257K and leaving 33,679 shares worth $2.55M. The position accounts for 2.06% of the portfolio, ranked #14.

MacNealy Hoover Investment Management first reported a position in ABBV in Q4 2013 and has held it in 24 quarters since. The position peaked at $2.72M in Q2 2019. 2,003 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

  • MacNealy Hoover Investment Management held 33,679 shares of AbbVie worth $2.55M as of Q3 2019.
  • MacNealy Hoover Investment Management sold 3,750 AbbVie shares in Q3 2019, an estimated $257K.
  • AbbVie made up 2.06% of MacNealy Hoover Investment Management's portfolio in Q3 2019, its #14 holding.
  • MacNealy Hoover Investment Management first reported a position in AbbVie in Q4 2013 and has held it in 24 quarters since.
  • MacNealy Hoover Investment Management's AbbVie position peaked at $2.72M in Q2 2019.
  • 2,003 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on MacNealy Hoover Investment Management's 13F filing for Q3 2019, filed 1 Oct 2019.